Suppr超能文献

符合条件的患者群体不断变化的人口统计学特征可能会影响生物标志物临床研究的入组情况。

Evolving demographics of eligible patient population can impact enrollment of a biomarker clinical study.

作者信息

Vettleson-Trutza Sara A, Pazdernik Vanessa K, Skalski Joseph H, Snyder Melissa R, Yang Yifei K

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America.

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, United States of America.

出版信息

PLoS One. 2025 May 9;20(5):e0323187. doi: 10.1371/journal.pone.0323187. eCollection 2025.

Abstract

In a prospective clinical study to better understand how biological markers can improve diagnosis of and prognosis for asthmatic and atopic conditions, we contacted over 3500 eligible patients and observed noticeable differences in the range of their likelihood to enroll based on gender (3.8-13.4%), race and ethnicity (4.8-29.8%), and distance to study site (1.1-29.2%). Both the eligible patients and enrolled participants exhibited a more diverse racial and ethnic composition compared to local population demographics. Based on the eligible patients that the study team contacted ("eligible patients", n = 3648) and those who agreed to enroll ("enrolled participants", n = 454), we analyzed the gender, age, race and ethnicity composition of the groups, together with their proximity to the study site. Living close to the study site was the largest contributor to a patient's decision to enroll for both adults (odds ratio OR: 2.26, 95% confidence interval CI: 1.64-3.15, p < 0.001) and children (OR: 2.59, 95% CI: 1.67-4.41, p < 0.001). We also observed that patients from White and non-Hispanic racial and ethnic background were more likely to participate in the study among both pediatric (OR: 1.51, CI: 0.92-2.62, p = 0.122) and adult patients (OR: 1.81, CI: 1.18-2.89, p = 0.009). Eligible patients of female gender were also more likely to enroll in both adult (OR: 1.53, CI: 1.16-2.05, p = 0.003) and pediatric groups (OR: 2.14, CI: 1.42-3.22, p < 0.001). Overall, the pediatric patients (18 years old or younger) were much less willing to participate in the clinical biomarker study. Nonetheless, as they age, the enrollment likelihood increased accordingly (5 years OR: 1.71, CI, 1.32-2.21, p < 0.001). The eligible patient population of the study reflected the evolving demographics and different disease prevalence for asthma and other allergic diseases in adult and pediatric groups. These factors in turn influenced the composition of the enrolled participants.

摘要

在一项前瞻性临床研究中,为了更好地了解生物标志物如何改善哮喘和特应性疾病的诊断及预后,我们联系了3500多名符合条件的患者,并观察到基于性别(3.8 - 13.4%)、种族和民族(4.8 - 29.8%)以及距离研究地点远近(1.1 - 29.2%),他们参与研究的可能性范围存在显著差异。与当地人口统计数据相比,符合条件的患者和已登记参与者的种族和民族构成更加多样化。基于研究团队联系的符合条件的患者(“符合条件的患者”,n = 3648)和同意参与的患者(“已登记参与者”,n = 454),我们分析了两组的性别、年龄、种族和民族构成,以及他们与研究地点的距离。居住在靠近研究地点是成年患者(优势比OR:2.26,95%置信区间CI:1.64 - 3.15,p < 0.001)和儿童患者(OR:2.59,95%CI:1.67 - 4.41,p < 0.001)决定参与研究的最大因素。我们还观察到,来自白人和非西班牙裔种族和民族背景的患者在儿科患者(OR:1.51,CI:0.92 - 2.62,p = 0.122)和成年患者(OR:1.81,CI:1.18 - 2.89,p = 0.009)中更有可能参与研究。女性符合条件的患者在成年组(OR:1.53,CI:1.16 - 2.05,p = 0.003)和儿科组(OR:2.14,CI:1.42 - 3.22,p < 0.001)中也更有可能参与。总体而言,儿科患者(18岁及以下)参与临床生物标志物研究的意愿要低得多。然而,随着年龄增长,参与的可能性相应增加(5岁时OR:1.71,CI:1.32 - 2.21,p < 0.001)。该研究符合条件的患者群体反映了成人和儿科组中哮喘及其他过敏性疾病不断变化的人口统计学特征和不同的疾病患病率。这些因素反过来又影响了已登记参与者的构成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f653/12063902/11093251469f/pone.0323187.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验